ROBERT DEVLIN: Open Payments
NPI 1093471153 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$162 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $140 · 2025 $162
Food & beverage: $162
| Company | Payments | Amount |
|---|---|---|
| Genentech USA, Inc. | 2 | $38 |
| Incyte Corporation | 1 | $28 |
| Legend Biotech USA Inc. | 1 | $27 |
| Janssen Scientific Affairs, LLC | 1 | $27 |
| ABBVIE INC. | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $18 |
Products named: CARVYKTI, TECVAYLI, EPKINLY, Venclexta, Polivy, ZEVTERA.
Industry payments across GA — which companies pay providers there.
